CYPHERPUNK TECHNOLOGIES INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-29.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-04-29
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-03-31 was 0.00%.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-03-31 was 0.00%.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-03-31 was 0.00%.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2022-03-31 was 0.00%.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2021 was 0.00%.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2020 was 0.00%.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2019 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | 0.00% DEF 14A · filed 2026-04-29 | |||||
| 2025-06-30 | 0.00% 10-Q · filed 2025-08-14 | |||||
| 2025-03-31 | 0.00% 10-Q · filed 2025-05-13 | |||||
| 2024-12-31 | 0.00% DEF 14A · filed 2026-04-29 | |||||
| 2024-09-30 | 0.00% 10-Q · filed 2025-11-12 | |||||
| 2024-06-30 | 0.00% 10-Q · filed 2025-08-14 | |||||
| 2024-03-31 | 0.00% 10-Q · filed 2025-05-13 | |||||
| 2023-12-31 | 0.00% DEF 14A · filed 2026-04-29 | |||||
| 2023-09-30 | 0.00% 10-Q · filed 2024-11-13 | |||||
| 2023-06-30 | 0.00% 10-Q · filed 2024-08-12 | |||||
| 2023-03-31 | 0.00% 10-Q · filed 2024-05-13 | |||||
| 2022-12-31 | 0.00% 10-K · filed 2024-03-18 | |||||
| 2022-09-30 | 0.00% 10-Q · filed 2023-11-13 | |||||
| 2022-06-30 | 0.00% 10-Q · filed 2023-08-14 | |||||
| 2022-03-31 | 0.00% 10-Q · filed 2023-05-15 | |||||
| 2021-12-31 | 0.00% 10-K · filed 2023-03-24 | |||||
| 2021-09-30 | 0.00% 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 0.00% 10-Q · filed 2022-08-12 | |||||
| 2021-03-31 | 0.00% 10-Q · filed 2022-05-13 | |||||
| 2020-12-31 | 0.00% 10-K · filed 2022-03-11 | |||||
| 2020-09-30 | 0.00% 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | 0.00% 10-Q · filed 2021-08-13 | |||||
| 2020-03-31 | 0.00% 10-Q · filed 2020-05-14 | |||||
| 2019-12-31 | 0.00% 10-K · filed 2021-03-12 | |||||
| 2019-09-30 | 0.00% 10-Q · filed 2019-11-14 | |||||
| 2019-06-30 | 0.00% 10-Q · filed 2019-08-09 | |||||
| 2019-03-31 | 0.89% 10-Q · filed 2020-05-14 | 0.00% 10-Q · filed 2019-05-15 | ||||
| 2018-12-31 | 2.07% 10-Q · filed 2020-05-14 | 0.00% 10-Q · filed 2019-05-15 | ||||
| 2018-09-30 | 0.00% 10-Q · filed 2018-11-09 | |||||
| 2018-06-30 | 0.00% 10-Q · filed 2018-08-08 | |||||
| 2018-03-31 | 0.00% 10-Q/A · filed 2018-08-08 | |||||
| 2017-12-31 | 0.00% 10-Q · filed 2018-11-09 | |||||
| 2017-09-30 | 0.00% 10-Q · filed 2017-11-13 | |||||
| 2017-06-30 | 0.00% 10-Q · filed 2017-08-11 | |||||
| 2017-03-31 | 0.00% 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |